The symposium attracts a diverse audience, including oncologists, surgeons, radiologists, pathologists, and researchers from both academia and industry. In addition, patient advocates, policymakers, and representatives from pharmaceutical companies also attend to gain insights into the latest trends and breakthroughs in breast cancer research and treatment.
